C. Lersch
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Florian Eckel (20 shared papers)Stefan Quasthoff (4 shared papers)Helmuth Adelsberger (3 shared papers)Julian Großkreutz (3 shared papers)Ewert Schulte‐Frohlinde (17 shared papers)Alexandra Lepier (1 shared paper)Stefan von Delius (10 shared papers)Martina Mayr (4 shared papers)
In The Last Decade
C. Lersch
60 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Oncology 551
- Hepatology 128
- Dermatology 129
- Internal Medicine 48
- Hematology 128
Countries citing papers authored by C. Lersch
This map shows the geographic impact of C. Lersch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lersch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lersch more than expected).
Fields of papers citing papers by C. Lersch
This network shows the impact of papers produced by C. Lersch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lersch. The network helps show where C. Lersch may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Lersch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 229 | |
| 2 | 2006 | 77 | |
| 3 | 2003 | 74 | |
| 4 | 2002 | 72 | |
| 5 | 2012 | 60 | |
| 6 | 2005 | 45 | |
| 7 | 2005 | 45 | |
| 8 | 2015 | 43 | |
| 9 | Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation. | 2004 | 34 |
| 10 | 1992 | 33 | |
| 11 | 2007 | 32 | |
| 12 | 2011 | 27 | |
| 13 | 2003 | 26 | |
| 14 | 2000 | 25 | |
| 15 | 2017 | 23 | |
| 16 | 1992 | 23 | |
| 17 | 2005 | 23 | |
| 18 | [The Saccharomyces boulardii therapy of HIV-associated diarrhea]. | 1993 | 21 |
| 19 | 1989 | 19 | |
| 20 | Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin. | 1990 | 19 |
About C. Lersch
C. Lersch is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology and Epidemiology, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Genomics and Diagnostics (5 papers), Liver Disease and Transplantation (4 papers), Herbal Medicine Research Studies (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Oncology (551 citations), Hepatology (128 citations), Dermatology (129 citations), Internal Medicine (48 citations) and Hematology (128 citations). C. Lersch has collaborated with scholars based in Germany, Austria and Singapore. Frequent co-authors include Florian Eckel, Stefan Quasthoff, Helmuth Adelsberger, Julian Großkreutz, Ewert Schulte‐Frohlinde, Alexandra Lepier, Stefan von Delius, Martina Mayr, Renate Schmelz and Henryk Dancygier. Their work appears in journals such as Cancer Investigation, Oncology, Journal of Clinical Oncology, Clinical Biomechanics and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.